Find comprehensive information on male hypogonadism diagnosis, including clinical documentation, medical coding (ICD-10, SNOMED CT), treatment options, and healthcare guidelines. Learn about testosterone deficiency, low testosterone levels, signs and symptoms, and laboratory testing for accurate diagnosis and optimal patient care. Explore resources for healthcare professionals on managing and documenting male hypogonadism in clinical settings.
Also known as
Testicular hypofunction
Male hypogonadism due to primary testicular dysfunction.
Hypogonadotropic hypogonadism
Male hypogonadism due to insufficient pituitary or hypothalamic function.
Other chromosomal abnormalities
Certain genetic conditions can cause male hypogonadism (e.g., Klinefelter syndrome).
Postprocedural hypoinsulinemia
Hypogonadism can be a consequence of certain medical procedures or treatments.
When to use each related code
| Description |
|---|
| Male Hypogonadism |
| Klinefelter Syndrome |
| Secondary Hypogonadism |
Patient presents with complaints consistent with male hypogonadism. Symptoms include decreased libido, erectile dysfunction, fatigue, and reduced muscle mass. Onset of symptoms was gradual over the past six months. Patient reports a history of normal puberty. Review of systems is notable for decreased energy levels and depressed mood. Physical exam reveals testicular atrophy with testicular volume less than 10 ml bilaterally. Secondary sexual characteristics are within normal limits. Differential diagnosis includes primary hypogonadism, secondary hypogonadism, Klinefelter syndrome, and medication-induced hypogonadism. Laboratory evaluation will include serum testosterone, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and prolactin levels. Initial treatment plan pending lab results may include testosterone replacement therapy (TRT) with intramuscular injections, transdermal gels, or subcutaneous pellets. Patient education provided regarding the benefits and risks of testosterone therapy, including potential side effects such as polycythemia, prostate enlargement, and sleep apnea. Follow-up appointment scheduled in four weeks to review lab results and assess response to treatment. ICD-10 code E29.1, male hypogonadism, will be used for billing purposes. Patient understands the plan and agrees to proceed.